NCT06336720View on ClinicalTrials.gov

PoNS® Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

September 30, 2025

Conditions
Chronic Stroke Survivors
Interventions
DEVICE

Portable Neuromodulation Stimulator (PoNS)

The active PoNS device delivers amplitude-controlled, biphasic pulses to the anterior superior surface of the tongue through gold-plated electrodes.

Trial Locations (5)

10591

Rehabologym Corp, Tarrytown

30309

Shepherd Center, Atlanta

32216

Brooks Rehabilitation, Jacksonville

02129

MGH Institute of Health Professions, Boston

02035

Neurology Center of New England, P.C., Foxborough

Sponsors

Lead Sponsor

Helius Medical Inc
All Listed Sponsors
lead

Helius Medical Inc

INDUSTRY

NCT06336720 - PoNS® Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study | Biotech Hunter | Biotech Hunter